in partnership with
DRC Logo
Get the Latest Updates

Sign up to receive emails from Retina Foundation that will keep you up-to-date on our research and events.

  • This field is for validation purposes and should be left unchanged.

Search by:


  • Clinical Research
  • Clinical Trials
  • Laboratory Research
  • News/ Press Release
  • Patient Resource
  • Patient Story


  • Age Related Macular Degeneration
  • Inherited Eye Diseases
  • Pediatric Eye Condition


  • Community Outreach
  • Special Needs Program
Reset Filters
Clinical Trials

June 29, 2021

Assessing Mobility Vision and Retinitis Pigmentosa

Scientists in the Rose-Silverthorne Retinal Degeneration Lab at the Retina Foundation recently began a new clinical trial utilizing a mobility …

Read More
Clinical Trials

June 16, 2020

Choroideremia Research Is Necessary to Help Prevent Blindness at an Early Age

Choroideremia is an X-linked, recessive, inherited retinal disorder that affects 1 in 50,000 individuals. X-linked refers to the X chromosome, …

Read More
Clinical Trials

October 1, 2019

Promising results from ongoing Phase 1/2 clinical trial for X-linked retinitis pigmentosa (XLRP)

The Retina Foundation of the Southwest is one of four U.S. centers conducting a Phase 1/2 dose escalation, gene replacement …

Read More
Clinical Trials

July 31, 2019

Retina Foundation Asks Kids to ‘Just Dance’ for Research Study

The Retina Foundation is an international leader in research on lazy eye, the most common cause of visual impairment in …

Read More
Clinical Trials

July 23, 2019

Gene Therapy Trial for Choroideremia

In a clinical research study headed by Dr. David Birch, scientists in the Rose-Silverthorne Retinal Degenerations Lab are testing the …

Read More
Clinical Trials

November 7, 2018

Phase III Treatment Trial for Stargardt Disease Enrolls First Patient

The Retina Foundation of the Southwest was the first site in the world to enroll patients in a new international …

Read More
Clinical Trials

August 31, 2018

Retina Foundation Participates in International Effort to Treat Stargardt Disease

Stargardt disease is the most common form of inherited juvenile macular degeneration. Stargardt disease begins in late childhood and may …

Read More
Clinical Trials

April 19, 2018

First Patient in Phase 1/2 Clinical Study of Gene Therapy is Treated for X-Linked RP

The first human patient has been administered an AAV-based gene therapy treatment for x-linked retinitis pigmentosa (XLRP). This is an exciting …

Read More
Clinical Trials

February 23, 2018

NIH Launches International Study of AMD Progression

Natural history investigation will deploy latest advances to identify biomarkers, targets for early therapy. A new clinical study led by …

Read More
Contact Us

Contact Us

  • This field is for validation purposes and should be left unchanged.

Please check all that apply:

How did you learn about the
Retina Foundation?

  • Please check all that apply:
  • This field is for validation purposes and should be left unchanged.
Contact Us

Request an Appointment

Please complete this form if you are interested in speaking to a member of our team about your AMD.

all fields required

DOWNLOAD Printable Form